Jia (Jenny) Liu: Strategies to Operationalize Wellbeing at an Individual Level at MOGA25
Jia (Jenny) Liu, Translational Lead of Early Phase Drug Development at The Kinghorn Cancer Centre, shared a post on LinkedIn:
“Medical Oncology Group of Australia MOGA25 annual meeting is around the corner next week in Melbourne!
Congrats Miles Andrews and Lavinia Spain on an incredible program ‘beyond the checkpoints’
I am particularly looking forward to:
Co-chairing with James Lynam the joint workforce session between MOGA and American Society of Clinical Oncology (ASCO) on strategies to operationalize wellbeing at an institutional and individual level. International superstars including Ishwaria Subbiah, MD, MS, FASCO, Fay Hlubocky and Andrew Furness.
Masterclass on novel IO management including cell therapy, biospecifics and TILs. Our phase 1/breast fellow Sarah Childs will be sharing insights on institutional setup of cell therapy at The Kinghorn Cancer Centre
Neoadjuvant therapies; shifting paradigms where I will be sharing insights in cutaneous SCC and Neoadjuvant approaches. Many 🇦🇺 colleagues driving translational, interventional and real world evidence in this space!
I also here there may be a debate involving dance and poetry at the ASM Dinner…
See you in Melbourne next week and reach out if you are there.
More posts featuring Jia (Jenny) Liu on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023